NRx Pharmaceuticals Advances Toward FDA Approval for NRX-100 Under New Priority Voucher Program
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, is making significant strides in the development and regulatory approval process of NRX-100, its preservative-free intravenous ketamine...
Texas Governor Vetoes Measure to Ban Consumable THC Products
Texas Governor Greg Abbott has vetoed a measure that sought to impose a ban on all consumable THC products within the state, a decision that maintains the availability of THC gummies, vape cartridges,...
Innovative Industrial Properties Inc. Emerges as a Leader in the Evolving Cannabis Industry
The cannabis industry has undergone significant transformation over the past five years, marked by challenges such as excessive spending, stringent tax burdens, and complex regulations. These hurdles ...
Missouri's New Cannabis Purchase Limits Spark Industry-Wide Attention
Medical marijuana advocates in Missouri are voicing concerns over newly introduced state guidelines that impose stricter limits on the amount of cannabis patients can purchase from dispensaries. These...
NRx Pharmaceuticals Enhances Corporate Communications Strategy with IBN to Advance Mental Health Treatments
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, has taken a significant step forward in its mission to develop groundbreaking treatments for mental health conditions such as suicidal ...
Pennsylvania's Budget Debate Could Influence Cannabis Legalization
As Governor Josh Shapiro and Pennsylvania's lawmakers work towards finalizing next year's budget by the July 1 deadline, the cannabis industry watches closely. The budget discussions, marked by disagr...
High-Security Cannabis Facility Highlights Industry's Growth and Challenges
The presence of a high-security cannabis facility, notable for its barbed wire enclosure and the unmistakable scent of cannabis, near a local sheriff's station, paints a vivid picture of the cannabis ...
Study Highlights Genetic Diversity Concerns in Legal Cannabis Industry
A new study on marijuana genetics has brought to light concerns regarding the legal cannabis industry's impact on the plant's genetic diversity. The industry's emphasis on cultivating faster-growing p...
Psyence Biomed's Chief of Global Impact to Speak at Psychedelic Science 2025
Psyence Biomed (NASDAQ: PBM) has announced that its Chief of Global Impact, Mary-Elizabeth Gifford, will be a featured speaker at Psychedelic Science 2025 (PS2025), the premier international conferenc...
Meta's Content Policy Shift Excludes Cannabis, Impacting Industry Visibility
Earlier this year, Meta announced a shift in its approach to handling controversial topics, opting to relax certain content rules around politically debated issues like gender identity and immigration...
Carolindica Introduces Nano THC Pops: A Summer Game-Changer in Cannabis Consumption
Carolindica, a North Carolina-based leader in the hemp industry, has unveiled its latest innovation, Nano THC Pops, designed to redefine summer cannabis consumption. These freezeable, drinkable, and m...
Congress Shifts Focus to Hemp-Derived THC Restrictions Amid Cannabis Industry Growth
The cannabis industry, a sector that has seen exponential growth and increasing legalization across the United States, is now facing a potential regulatory shift as Congress turns its attention to res...
Perfect Union to Highlight Community Engagement at Morro Bay Seminar
Perfect Union, a flagship retail brand under MWG Holdings Group, Inc., is set to sponsor and participate in the Breakfast on the Bay seminar hosted by the Morro Bay Chamber of Commerce. The event, tit...
Illicit Cannabis Sales in the UK Highlight Need for Policy Reform
The recent discovery of stickers promoting illicit cannabis sales in Burton upon Trent, featuring a QR code linking to a website offering various cannabis products, has brought to light the growing is...
Cybin Advances CYB003 into Phase 3 Development, Highlighting Progress in Psychedelic Therapeutics
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) has announced a significant milestone in its clinical pipeline with the advancement of CYB003, its lead candidate, into Phase 3 development. This progress ...
Federal Immigration Enforcement and the Cannabis Industry: Navigating Compliance Challenges
The intersection of federal immigration enforcement and the cannabis industry presents a unique challenge for businesses operating in states where marijuana has been legalized. Despite the growing acc...
Cybin CEO to Discuss Next-Gen Neuropsychiatric Treatments at H.C. Wainwright Conference
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), a clinical-stage biopharmaceutical company, has announced that its Chief Executive Officer, Doug Drysdale, will participate in a virtual fireside chat at ...
NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Amid National Shortage
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, has taken a significant step towards addressing the current ketamine shortage in the United States by filing an Abbreviated New Drug Ap...
CannabisRadio.com Celebrates a Decade of Pioneering Cannabis and Psychedelic Media
For 10 years, CannabisRadio.com has been the pulse of plant-powered progress—amplifying stories of innovation, advocacy, and wellness across cannabis, plant medicine, and biohacking. A decade in, the ...
Missouri Launches Initiative to Ensure Cannabis Product Safety
Starting next month, Missouri's Division of Cannabis Regulation will implement a new safety initiative, conducting unannounced visits to dispensaries to collect and test cannabis products for harmful ...
Silo Pharma Secures U.S. Patent for PTSD Treatment Biomarkers, Advancing Clinical Trials
Silo Pharma (NASDAQ: SILO) has achieved a pivotal milestone with the U.S. Patent and Trademark Office issuing a Notice of Allowance for its licensed patent application concerning biomarkers for evalua...
Cybin CEO to Speak at Psychedelic Science 2025 Conference on Advancing Mental Health Treatments
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) has announced that its CEO, Doug Drysdale, is set to speak at the upcoming Psychedelic Science 2025 Conference in Denver. Scheduled for June 16–20, the con...
Texas Moves Closer to Banning THC-Infused Products as Governor Abbott Reviews New Bill
The Texas legislature has taken a significant step towards banning a variety of THC-infused products, including vapes, edibles, and beverages, with a newly approved bill now awaiting Governor Greg Abb...
THCA Flower's Legal Status Under Scrutiny as Industry Watches Closely
The cannabis industry is currently navigating the complex legal landscape surrounding THCA flower, a compound derived from hemp that exists in a gray area of federal law. Steven Brown, CEO of Nothing ...
Alternative Products Expo Expands to Nashville, Highlighting Cannabis and Psychedelic Industries
The Alternative Products Expo is set to make its mark in Nashville, continuing its tradition since 2017 of bringing together manufacturers, retailers, enthusiasts, and entrepreneurs from the countercu...
The Rising Role of Cannabis in Cancer Care Highlighted by Industry Leaders
With over two million individuals in Canada and the U.S. receiving a cancer diagnosis each year, the search for effective treatments and relief options has never been more critical. Among the most com...
NRx Pharmaceuticals Expands Mental Health Treatment Network with Kadima Neuropsychiatry Institute Acquisition
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company recognized for its treatments targeting suicidal bipolar depression and acute suicidal depression, has entered into a definitive agreeme...
NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Formulation Amid National Shortage
NRx Pharmaceuticals (NASDAQ: NRXP) has taken a significant step forward in the ketamine market by submitting an Abbreviated New Drug Application (ANDA) to the FDA for NRX-100, its preservative-free in...